Connect with Us at the Upcoming Events

With in-person events back again, Creative Biolabs is excited to greet you at the upcoming international conferences. Meet our team at 2022 BIO International Convention in June (booth #1754) and at the 13th Annual World ADC San Diego in September (booth number to be updated) for expert consultation on your drug discovery. Shoot an email to arrange an in-person meeting!

Book a Meeting

Orela O-Glycan Release kit [For Glycan Release] (CAT#: CB-P274-K) Datasheet

Product Type
The kit contains reagents for releasing O-linked glycans from glycoprotein biopharmaceuticals. The released glycans have free reducing ends and can be fluorescently labeled by reductive amination.
Number of Samples: The kit contains reagents and materials for up to 12 glycoprotein samples analysed in parallel or two sets of 6 samples.
Amount of Sample: Typically, up to 1 mg of glycoprotein per sample.
Suitable Samples: Biopharmaceutical glycoproteins.
For release of O-linked glycans from glycoprotein therapeutics
Glycoproteins and glycopeptides containing N-linked glycans
Orela Release Reagent 2 x 3ml
Acetic Acid Solution 2 x 3 ml
CreaClean™ CEX-H cartridges 2 x 6 cartridges
Glass reaction vials with PTFE lined caps 2 x 6 vials
Glass collection vials with PTFE lined caps 2 x 6 vial
Handling Advice
1. Add up to 1 nmole of oligosaccharide to a tube.
2. Add de-ionized water to a total of 15 µL.
3. Add 4 µL of 5x Reaction Buffer 5.0.
4. Add 1 µL of α(1-3,4)-Fucosidase.
5. Incubate for 1 hour at 37°C.
The product should be shipped at ambient temperature.
Store refrigerated at 4 to 10 °C in the dark.
Shelf Life
Stability: Stable at least 12 months when stored properly. Several days exposure to ambient tempertures will not reduce activity.
Research Use
For research use only. Not for human or drug use

All products and services are for Research Use Only. Do Not use in humans.


Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *